tiprankstipranks
Biogen Inc. (DE:IDP)
NASDAQ:IDP
Germany Market
IDP
Biogen
RESEARCH TOOLSreports

Biogen (IDP) Ratios

6 Followers

Biogen Ratios

DE:IDP's free cash flow for Q1 2026 was $0.73. For the 2026 fiscal year, DE:IDP's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.06 2.68 1.35 2.00 2.99
Quick Ratio
 2.41 2.03 0.90 1.26 2.58
Cash Ratio
 1.13 0.90 0.43 0.31 1.04
Solvency Ratio
 0.21 0.20 0.20 0.14 0.32
Operating Cash Flow Ratio
 0.86 0.66 0.52 0.45 0.42
Short-Term Operating Cash Flow Coverage
 0.00 27.42 1.64 10.31 0.00
Net Current Asset Value
$ -1.64B$ -2.21B$ -3.88B$ -5.19B$ -1.37B
Leverage Ratios
Debt-to-Assets Ratio
 0.22 0.24 0.24 0.27 0.27
Debt-to-Equity Ratio
 0.35 0.38 0.40 0.50 0.49
Debt-to-Capital Ratio
 0.26 0.28 0.28 0.33 0.33
Long-Term Debt-to-Capital Ratio
 0.25 0.26 0.21 0.31 0.32
Financial Leverage Ratio
 1.58 1.61 1.68 1.81 1.83
Debt Service Coverage Ratio
 9.79 9.17 1.36 5.65 11.78
Interest Coverage Ratio
 5.61 7.63 9.95 8.49 11.72
Debt to Market Cap
 0.22 0.26 0.28 0.19 0.16
Interest Debt Per Share
 46.45 49.04 47.22 52.42 47.22
Net Debt to EBITDA
 1.14 1.27 1.42 2.65 0.90
Profitability Margins
Gross Profit Margin
69.77%70.47%76.12%74.24%77.61%
EBIT Margin
19.28%22.07%24.00%19.14%29.67%
EBITDA Margin
28.29%31.60%30.96%24.17%34.77%
Operating Profit Margin
15.65%19.14%25.74%21.32%28.40%
Pretax Profit Margin
14.89%14.29%19.70%13.18%35.33%
Net Profit Margin
13.92%13.18%16.87%11.81%29.95%
Continuous Operations Profit Margin
13.92%13.18%16.87%11.81%29.11%
Net Income Per EBT
93.49%92.29%85.63%89.54%84.77%
EBT Per EBIT
95.18%74.65%76.54%61.83%124.41%
Return on Assets (ROA)
4.65%4.39%5.82%4.33%12.41%
Return on Equity (ROE)
7.55%7.08%9.76%7.85%22.74%
Return on Capital Employed (ROCE)
5.82%7.20%11.06%8.96%13.58%
Return on Invested Capital (ROIC)
5.44%6.62%8.79%7.97%11.19%
Return on Tangible Assets
9.84%9.39%13.74%9.47%17.97%
Earnings Yield
4.76%5.01%7.33%3.10%7.57%
Efficiency Ratios
Receivables Turnover
 5.51 5.25 5.18 4.68 4.76
Payables Turnover
 8.31 6.71 5.45 6.28 4.64
Inventory Turnover
 1.53 1.34 0.94 1.00 1.69
Fixed Asset Turnover
 3.02 2.95 2.74 2.64 2.75
Asset Turnover
 0.33 0.33 0.34 0.37 0.41
Working Capital Turnover Ratio
 1.67 2.60 3.62 1.98 2.02
Cash Conversion Cycle
 261.10 288.20 392.19 383.96 213.29
Days of Sales Outstanding
 66.29 69.46 70.50 77.93 76.65
Days of Inventory Outstanding
 238.71 273.16 388.71 364.14 215.38
Days of Payables Outstanding
 43.91 54.43 67.02 58.11 78.74
Operating Cycle
 305.01 342.63 459.21 442.07 292.03
Cash Flow Ratios
Operating Cash Flow Per Share
 17.60 15.03 19.74 10.69 9.53
Free Cash Flow Per Share
 17.82 13.98 17.27 8.54 7.87
CapEx Per Share
 0.22 1.05 2.47 2.15 1.65
Free Cash Flow to Operating Cash Flow
 1.01 0.93 0.87 0.80 0.83
Dividend Paid and CapEx Coverage Ratio
 80.21 14.33 7.99 4.97 5.76
Capital Expenditure Coverage Ratio
 80.21 14.33 7.99 4.97 5.76
Operating Cash Flow Coverage Ratio
 0.39 0.32 0.43 0.21 0.21
Operating Cash Flow to Sales Ratio
 0.26 0.22 0.30 0.16 0.14
Free Cash Flow Yield
9.07%7.94%11.29%3.30%2.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 20.95 19.96 13.65 32.25 13.21
Price-to-Sales (P/S) Ratio
 2.93 2.63 2.30 3.81 3.96
Price-to-Book (P/B) Ratio
 1.54 1.41 1.33 2.53 3.00
Price-to-Free Cash Flow (P/FCF) Ratio
 10.99 12.59 8.86 30.30 35.17
Price-to-Operating Cash Flow Ratio
 11.10 11.71 7.75 24.20 29.07
Price-to-Earnings Growth (PEG) Ratio
 -2.69 -0.95 0.34 -0.52 0.13
Price-to-Fair Value
 1.54 1.41 1.33 2.53 3.00
Enterprise Value Multiple
 11.48 9.60 8.86 18.40 12.28
Enterprise Value
 32.12B 29.76B 26.54B 43.73B 43.43B
EV to EBITDA
 11.51 9.60 8.86 18.40 12.28
EV to Sales
 3.26 3.03 2.74 4.45 4.27
EV to Free Cash Flow
 12.24 14.51 10.55 35.39 37.96
EV to Operating Cash Flow
 12.40 13.50 9.23 28.27 31.37
Tangible Book Value Per Share
 21.12 17.64 3.75 1.50 39.84
Shareholders’ Equity Per Share
 126.71 124.45 114.73 102.28 92.21
Tax and Other Ratios
Effective Tax Rate
 0.07 0.08 0.14 0.10 0.18
Revenue Per Share
 66.97 66.88 66.41 67.97 70.02
Net Income Per Share
 9.32 8.82 11.20 8.02 20.97
Tax Burden
 0.93 0.92 0.86 0.90 0.85
Interest Burden
 0.77 0.65 0.82 0.69 1.19
Research & Development to Revenue
 0.20 0.20 0.26 0.27 0.26
SG&A to Revenue
 0.25 0.25 0.25 0.25 0.23
Stock-Based Compensation to Revenue
 0.03 0.03 0.03 0.03 0.02
Income Quality
 1.89 1.71 1.76 1.33 0.47
Currency in USD